Great Valley Advisor Group, Inc. Eli Lilly & CO Transaction History

Great Valley Advisor Group, Inc.

$3.84 Billion
Q3 2024

A detailed history of Great Valley Advisor Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 23,094 shares of LLY stock, worth $17.3 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

23,094

Previous 21,377 8.03%

Holding current value

$17.3 Million

Previous $19.4 Million 5.71%

% of portfolio

0.53%

Previous 0.56%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $1.33 Million - $1.65 Million	1,717 Added 8.03%	23,094 $20.5 Million
Q2 2024 Jul 16, 2024	BUY	$724.87 - $909.04 $785,034 - $984,490	1,083 Added 5.34%	21,377 $19.4 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $1.98 Million - $2.64 Million	3,338 Added 19.69%	20,294 $15.8 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $878,117 - $1.04 Million	-1,672 Reduced 8.98%	16,956 $9.88 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $299,073 - $412,318	688 Added 3.84%	18,628 $10 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $353,545 - $472,731	-1,008 Reduced 5.32%	17,940 $8.41 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $1.91 Million - $2.24 Million	-6,142 Reduced 24.48%	18,948 $6.51 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $2.55 Million - $2.97 Million	7,919 Added 46.12%	25,090 $9.18 Million
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $1.41 Million - $1.6 Million	-4,748 Reduced 21.66%	17,171 $5.55 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $2.32 Million - $2.72 Million	8,313 Added 61.1%	21,919 $7.11 Million
Q1 2022 Apr 20, 2022	BUY	$234.69 - $291.66 $87,539 - $108,789	373 Added 2.82%	13,606 $3.89 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $29,905 - $37,112	133 Added 1.02%	13,233 $3.61 Million
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $138,056 - $169,898	623 Added 4.99%	13,100 $3.03 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $128,190 - $165,813	-710 Reduced 5.38%	12,477 $2.82 Million
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $885,520 - $1.15 Million	-5,389 Reduced 29.01%	13,187 $2.46 Million
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $114,282 - $151,223	876 Added 4.95%	18,576 $3.14 Million
Q3 2020 Oct 21, 2020	BUY	$146.22 - $169.13 $1.16 Million - $1.35 Million	7,960 Added 81.72%	17,700 $2.62 Million
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $1.33 Million - $1.6 Million	9,740 New	9,740 $1.6 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Account

Great Valley Advisor Group, Inc. Eli Lilly & CO Transaction History